Clinical Trial Update: Short-term Efficacy of Intravitreal Afilibercept Depending on Subtypes of Polypoidal Choroidal Vasculopathy: Polypoidal Choroidal Neovascularization or Idiopathic Choroidal Vasculopathy

View source ↗

Summary

Clinical trial update assessing the short-term efficacy of intravitreal aflibercept in subtypes of Polypoidal Choroidal Vasculopathy (polypoidal choroidal neova…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Polypoidal Choroidal Vasculopathy

Drugs mentioned

• Eylea (aflibercept) (aflibercept)

Snippet

Sponsor: Yeungnam University College of Medicine | Conditions: Polypoidal Choroidal Vasculopathy | Status: UNKNOWN | Results posted: 2016-06-17